Artemis Medicare Services Ltd
NSE:ARTEMISMED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Artemis Medicare Services Ltd
NSE:ARTEMISMED
|
IN |
|
G
|
GV Films Ltd
BSE:523277
|
IN |
|
D
|
Dentsu Group Inc
XMUN:DEN
|
JP |
|
D
|
Dhampur Sugar Mills Ltd
BSE:500119
|
IN |
|
Iwasaki Electric Co Ltd
TSE:6924
|
JP |
|
F
|
Finnair Oyj
OMXH:FIA1S
|
FI |
|
B
|
Baird Medical Investment Holdings Ltd
NASDAQ:BDMD
|
HK |
|
H
|
Hut 8 Corp
F:V71
|
US |
Wall Street
Price Targets
ARTEMISMED Price Targets Summary
Artemis Medicare Services Ltd
According to Wall Street analysts, the average 1-year price target for
ARTEMISMED
is 333.2 INR
with a low forecast of 272.7 INR and a high forecast of 388.5 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ARTEMISMED's stock price target?
Price Target
333.2
INR
According to Wall Street analysts, the average 1-year price target for
ARTEMISMED
is 333.2 INR
with a low forecast of 272.7 INR and a high forecast of 388.5 INR.
What is Artemis Medicare Services Ltd's Revenue forecast?
Projected CAGR
22%
For the last 5 years the
compound annual growth rate for
Artemis Medicare Services Ltd's revenue is
11%.
The projected
CAGR
for the next 3 years is
22%.
What is Artemis Medicare Services Ltd's Operating Income forecast?
Projected CAGR
40%
For the last 5 years the
compound annual growth rate for
Artemis Medicare Services Ltd's operating income is
22%.
The projected
CAGR
for the next 3 years is
40%.
What is Artemis Medicare Services Ltd's Net Income forecast?
Projected CAGR
36%
For the last 5 years the
compound annual growth rate for
Artemis Medicare Services Ltd's net income is
33%.
The projected
CAGR
for the next 3 years is
36%.
